atherosclerosis, normo-cholesterol adults with type 2 diabetes
DISEASE INTERVENTION COMPARISON RESULTS
Lancet. 2005 Nov 26;366(9500):1849-61 Randomized Controlled Trial, Multicenter Study
IN atherosclerosis, normo-cholesterol adults with type 2 diabetes The Use of
fibrates, fenofibrate 200 mg daily
As Treatment, Chronic
Is equal Than
placebo
To prevent coronary events (combined myocardial infarction or coronary death: 5.9% with placebo VS 5.2% with fibrates) or to reduce total mortality.